Glucose disturbances in non-diabetic patients receiving acute treatment with methylprednisolone pulses;Distúrbios de glicose em pacientes não diabéticos que recebem tratamento agudo com pulsos de metilprednisolona

Revista da Associacao Medica Brasileira

Volumn 58, Issue 1, 2012, Pages 125-128

  Perez, Hector Eloy Tamez ^a   Ossio, María Dolores Gómez de ^b   Flores, Dania Lizet Quintanilla ^a   Coria, Mayra Ivonne Hernández ^c   Peña, Alejandra Lorena Tamez ^a   Pérez, Gissén Jazmín Cuz ^b   Peña, Stephanie Lissette Proskauer ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

Diabetes mellitus; Hyperglycemia; Methylprednisolone

Indexed keywords

EID: 84858041311     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302012000100025     Document Type: Article

References (15)

1. Roubenoff R, Roubenoff RA, Ward LM, Stevens MB. Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis. Am J Clin Nutr. 1990;52:1113-7.
2. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opinion Rheumatol. 2008;20:131-7.
3. Saigi I, Pérez A. Manejo de la hiperglucemia inducida por esteroides. Rev Clin Esp. 2010;210:397-403.
4. Feldman-Billard S, Kassaei R, Benrabah R, Lissak B, Heron E. Glucose tolerance of high-dose intravenous methylprednisolone therapy in ophthalmology. J Fr Ophtalmol. 2004;27:160-1.
5. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15:469-74.
6. F-Vázquez SM. Manejo de la hiperglucemia secundaria al tratamiento con corticoides. Av Diabetol. 2006;22:194-9.
7. Tamez-Perez HE, Cisneros-Perez V, Cedillo-Rodriguez JA, Diaz-De-Leon- Gonzalez E, Torres-Valenzuela M, Tamez-Pena AL, et al. Prevalence of hypokalemia in patients with methylprednisolone pulse therapy. Rev Invest Clin. 2009;61:194-7.
8. Pandit MK, Burke J, Gustafson AB, Minocha A, Peiris AN. Drug-induced disorders of glucose tolerance. Ann Intern Med. 1993;7:529-39.
9. Abdelmannan DA, Tahboub R, Genuth S, Ismail-Beigi F. Effect of dexamethasone on oral glucose tolerance in healthy adults. Endocr Pract. 2010;15:770-7.
10. Mignogna MD, Muzio LO, Ruoppo E, Fedele S, Russo LO, Bussi E. High-dose intravenous "pulse" methylprednisolone in the treatment of severe oropharyngeal pemphigus: a pilot study. J Oral Pathol Med. 2002;31:339-44.
11. Hansen KB, Vilsboll T, Bagger JI, Holst JJ, Knop FK. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab. 2010;3309-17.
12. Peralta FG, Padin CA. Glucemia postprandial y variabilidad glucémica: nuevos objetivos para conseguir el control glucémico óptimo en los pacientes con diabetes tipo 2. Av Diabetol. 2009;25:419-21.
13. Yang Z, Laubach VE, French BA, Kron IL. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg. 2009;137:723-9.
14. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8:1663-9.
15. Hans P, Vanthuyne A, Dewandre PY, Brichant JF, Bonhomme V. Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anesth. 2006;97:164-70.